and Bruce Armitage, have nearly 40 years of combined experience in nucleic acids chemistry and biology. The γPNA technology was created and developed in their laboratories at Carnegie Mellon University and exclusively licensed by PNA Innovations. The company envisions becoming a leader in the market by providing a superior product with synthetic flexibility, functional group diversity, and competitive pricing that delivers entirely new technologies to the customer.